U.S. Markets closed

Pascal Biosciences Inc. (PAS.V)

TSXV - TSXV Real Time Price. Currency in CAD
Add to watchlist
0.0850+0.0050 (+6.25%)
At close: 1:58PM EDT
Full screen
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close0.0800
Open0.0800
Bid0.0800 x N/A
Ask0.0900 x N/A
Day's Range0.0800 - 0.0850
52 Week Range0.0650 - 0.4500
Volume23,463
Avg. Volume91,247
Market Cap5.533M
Beta (5Y Monthly)1.35
PE Ratio (TTM)N/A
EPS (TTM)-0.0220
Earnings DateApr 23, 2019
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • ACCESSWIRE

    Pascal Biosciences Announces Management Changes

    VANCOUVER, BC / ACCESSWIRE / March 22, 2021 / Pascal Biosciences Inc. ("Pascal" or the "Company") (TSXV:PAS)(OTC PINK:BIMUF), a biotechnology company that specializes in cancer, cannabinoids, and Covid-19 is announcing several management changes following its recent capital raise.

  • ACCESSWIRE

    Pascal Biosciences Inc. Closes Second Tranche of Non-Brokered Private Placement of $750,000

    NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATESVANCOUVER, BC / ACCESSWIRE / March 17, 2021 / Pascal Biosciences Inc. ("Pascal" or the "Company") (TSXV:PAS)(OTC PINK:BIMUF), a biotechnology company that specializes in cancer, cannabinoids, and Covid-19 is pleased to announce the closing of the second tranche of the non-brokered private placement announced on November 2, 2020, January 19, 2021 and January 22, 2021 (the "Private Placement").

  • ACCESSWIRE

    Pascal Biosciences to Present at Cannabinoid Derived Pharmaceuticals Industry Review Summit

    SEATTLE, WA and VANCOUVER, BC / ACCESSWIRE / January 21, 2021 / Pascal Biosciences, Inc. ("Pascal" or the "Company") (TSXV:PAS)(OTC PINK:BIMUF), will present at the first Cannabinoid Derived Pharmaceuticals Industry Review Summit today.